Using patient-reported outcomes to improve survivorship care

Abstract

In this issue of Blood, Yen and colleagues report that adult survivors of pediatric hematologic malignancies have high symptom prevalence and poor patient-reported outcomes (PROs), whether treated with conventional therapy or hematopoietic stem cell transplantation (HSCT), and that the poor PROs correlated with the presence of chronic health conditions.1.